Researchers identify genetic changes responsible for rare childhood immune disorders Affecting the immune system, various forms of SCID are estimated to affect one in 75,000 to 100,000 newborns
MHRA approves Marinus Pharmaceuticals’ Ztalmy for CDKL5 deficiency disorder The rare epileptic seizure disorder currently affects around one in 42,000 people in the UK